5 Stocks To Watch For October 8, 2021
Some of the stocks that may grab investor focus today are:
White House Advisor ZIents Says Quidel, OraSure Are Further/More Rapidly Expanding Production Of Their Tests To Get More Capacity Of The Market
https://twitter.com/davidalim/status/1445827538547138564
Employer Demand For Rapid COVID-19 Tests Deepen Shortage In US: Reuters
In recent weeks, an increase in demand for COVID-19 tests from U.S.
FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations
The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests.
Quidel To Bring OTC COVID-19 Antigen Test To CVS Pharmacy
Quidel Corporation’s (NASDAQ:QDEL) non-prescription QuickVue At-Home OTC COVID-19 Test will be available next week at CVS Pharmacy locations across the U.S. and online…
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 1)
Return on Capital Employed Insights for Quidel
Pulled from Benzinga Pro data Quidel (NASDAQ:QDEL) posted Q2 earnings of $24.33 million, an increase from Q1 of 89.18%. Sales dropped to $176.61 million, a 52.95% decrease between quarters.
